Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the
Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is …

The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a
Controversies Conference on glomerular diseases in November 2017. The conference …

Glomerulonephritis (GN) is an important cause of morbidity and mortality in patients of all
ages throughout the world. Because these disorders are relatively rare, it is difficult to …

In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative
brought a diverse panel of experts in glomerular diseases together to discuss the 2012 …

Abstract The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline for Glomerulonephritis (GN) aims to assist practitioners caring for adults and …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

The KDIGO guideline for glomerulonephritis is designed to assist health-care providers in
treating patients with glomerular diseases. A guideline is not a set of rules but is intended to …

Abstract The Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice
Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) serves to …

Chinese translation Description: The Kidney Disease: Improving Global Outcomes (KDIGO)
organization developed clinical practice guidelines in 2012 to provide guidance on the …